Literature DB >> 11242217

CT features of primary colorectal signet-ring cell carcinoma.

H J Kim1, H K Ha, K S Cho, E Yu, J C Kim, C S Yoo, H C Kim, S K Yang, H Y Jeong, Y H Auh.   

Abstract

PURPOSE: The purpose of this work was to evaluate the CT features of 15 patients with primary colorectal signet-ring cell carcinomas.
METHOD: We retrospectively reviewed the CT scans of 15 patients (mean age 44 years) with pathologically proved colorectal signet-ring cell carcinoma. On CT, we evaluated the site and length of the tumor, bowel wall thickening patterns, perirectal or pericolic infiltration, the presence or absence of colonic obstruction, and metastasis to other organs.
RESULTS: The tumors were located in the rectum in nine patients, the sigmoid colon in one, the hepatic flexure in one, the transverse colon in one, the ascending colon in two, and the cecum in one. The tumor length ranged from 4.0 to 10.0 cm (mean 6.1 cm) with mean thickness of 2.1 cm. CT showed concentric bowel wall thickening in all patients ("even" in 8 and "uneven" in 7), target appearance was noted in 4, perirectal or pericolic infiltrations were moderate to severe in 12, and colorectal obstruction was seen in 6. In the tumor spread patterns, lymphadenopathy was noted in 13, invasion to adjacent pelvic organs in 5, peritoneal carcinomatosis in 4, liver metastasis in 2, and periureteric metastasis in 1.
CONCLUSION: Primary signet-ring cell colorectal carcinoma should be included for differential consideration when CT shows a long length of concentric bowel wall thickening and target sign, especially when such findings occur in the rectum and in young patients.

Entities:  

Mesh:

Year:  2001        PMID: 11242217     DOI: 10.1097/00004728-200103000-00011

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  8 in total

Review 1.  Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation.

Authors:  Nam Kyung Lee; Suk Kim; Hyun Sung Kim; Tae Yong Jeon; Gwang Ha Kim; Dong Uk Kim; Do Youn Park; Tae Un Kim; Dae Hwan Kang
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Case report and review of the literature: Rectal linitis plastica secondary to the lipoid cell variant of transitional cell carcinoma of the urinary bladder.

Authors:  Victor A McPherson; Michael Ott; Edward J Tweedie; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

3.  Signet-ring cell carcinoma of the appendix: a case report with an emphasis on sonographic findings.

Authors:  Young Jong Cho; Hyuk Jung Kim; Suk Ki Jang; Jae Woo Yeon; Ki-Ho Kim; So Ya Paik
Journal:  Ultrasonography       Date:  2015-11-24

4.  Role of CT scan in differentiating the type of colorectal cancer.

Authors:  Zhen-Hui Li; Ding-Yun You; De-Pei Gao; Guang-Jun Yang; Xing-Xiang Dong; Da-Fu Zhang; Ying-Ying Ding
Journal:  Onco Targets Ther       Date:  2017-04-26       Impact factor: 4.147

5.  Sonographic Findings of Malignant Appendix Tumors in Seven Cases.

Authors:  Kyung Su Kwag; Hyuk Jung Kim; Suk Ki Jang; Jae Woo Yeon; Soya Paik; Byeong Geon Jeon; Ki Ho Kim; Ji Hoon Park; Eun Shin
Journal:  J Med Ultrasound       Date:  2018-03-28

6.  Characteristics of primary signet ring cell carcinoma of colon and rectum: a case control study.

Authors:  Meng-Tzu Weng; Ko-Han Chao; Chien-Chih Tung; Hao-Chun Chang; I-Lun Shih; Been-Ren Lin; Ming-Jium Shieh; Chia-Tung Shun; Jau-Min Wong; Shu-Chen Wei
Journal:  BMC Gastroenterol       Date:  2022-04-08       Impact factor: 3.067

7.  Odd localisation for a gastric cancer histology.

Authors:  Paulina Kuczma; Jordi Vidal Fortuny; Saiji Essia; Ariane de Lassus; Philippe Morel; Frédéric Ris
Journal:  Int J Surg Case Rep       Date:  2016-07-27

8.  Metastatic Gastric Signet Ring Cell Carcinoma Mimicking Crohn's Disease.

Authors:  Michael W Winter; Amr Dokmak; Zachary Marnoy; Shweta Sinagare; Alexander N Levy
Journal:  ACG Case Rep J       Date:  2018-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.